Achieve Life Sciences, Inc. Increase (Decrease) in Accrued Liabilities
Achieve Life Sciences, Inc. (ACHV) reported Increase (Decrease) in Accrued Liabilities of -$307.00 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2019-08-08
- Achieve Life Sciences, Inc. increase (decrease) in accrued liabilities for the quarter ending 2019-06-30 was -$1.19M, a 15025.00% decline year-over-year.
- Achieve Life Sciences, Inc. increase (decrease) in accrued liabilities for the quarter ending 2019-03-31 was $887.00K.
- Achieve Life Sciences, Inc. increase (decrease) in accrued liabilities for the quarter ending 2018-12-31 was $532.00K, a 25.59% decline year-over-year.
- Achieve Life Sciences, Inc. increase (decrease) in accrued liabilities for the quarter ending 2018-09-30 was -$115.00K, a 103.26% decline year-over-year.
- Achieve Life Sciences, Inc. increase (decrease) in accrued liabilities for fiscal 2018 was $322.00K, a 63.28% decline from fiscal 2017.
- Achieve Life Sciences, Inc. increase (decrease) in accrued liabilities for fiscal 2017 was $877.00K.
- Achieve Life Sciences, Inc. increase (decrease) in accrued liabilities for fiscal 2016 was -$6.55M.
- Achieve Life Sciences, Inc. increase (decrease) in accrued liabilities for fiscal 2015 was -$3.71M, a 270.52% decline from fiscal 2014.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2019-06-30 | -$1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$307.00K 10-Q · filed 2019-08-08 | $225.00K derived: sum of 3 quarters · filed 2019-08-08 | $110.00K derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2019-03-31 | $887.00K 10-Q · filed 2019-05-15 | $1.42M derived: sum of 2 quarters · filed 2019-05-15 | $1.30M derived: sum of 3 quarters · filed 2019-05-15 | $1.31M derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2018-12-31 | $532.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $417.00K derived: sum of 2 quarters · filed 2019-03-14 | $425.00K derived: sum of 3 quarters · filed 2019-08-08 | $322.00K 10-K · filed 2019-03-14 | ||
| 2018-09-30 | -$115.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$107.00K derived: sum of 2 quarters · filed 2019-08-08 | -$210.00K 10-Q · filed 2018-11-07 | $505.00K derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2018-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$95.00K 10-Q · filed 2019-08-08 | $620.00K derived: sum of 3 quarters · filed 2019-08-08 | $4.15M derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2018-03-31 | -$103.00K 10-Q · filed 2019-05-15 | $612.00K derived: sum of 2 quarters · filed 2019-05-15 | $4.14M derived: sum of 3 quarters · filed 2019-05-15 | $3.85M derived: sum of 4 quarters · filed 2019-05-15 | ||
| 2017-12-31 | $715.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $4.24M derived: sum of 2 quarters · filed 2019-03-14 | $3.95M derived: sum of 3 quarters · filed 2019-03-14 | $877.00K 10-K · filed 2019-03-14 | ||
| 2017-09-30 | $3.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $3.23M derived: sum of 2 quarters · filed 2018-11-07 | $162.00K 10-Q · filed 2018-11-07 | -$3.54M derived: sum of 4 quarters · filed 2018-11-07 | ||
| 2017-06-30 | -$292.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | -$3.37M 10-Q · filed 2017-07-31 | -$7.06M derived: sum of 3 quarters · filed 2017-07-31 | -$7.65M derived: sum of 4 quarters · filed 2017-07-31 | ||
| 2017-03-31 | -$3.07M 10-Q · filed 2017-05-15 | -$6.77M derived: sum of 2 quarters · filed 2017-05-15 | -$7.36M derived: sum of 3 quarters · filed 2017-05-15 | -$8.11M derived: sum of 4 quarters · filed 2017-07-31 | ||
| 2016-12-31 | -$3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$4.29M derived: sum of 2 quarters · filed 2017-02-23 | -$5.04M derived: sum of 3 quarters · filed 2017-07-31 | -$6.55M 10-K · filed 2017-02-23 | ||
| 2016-09-30 | -$589.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$1.34M derived: sum of 2 quarters · filed 2017-07-31 | -$2.85M 10-Q · filed 2016-11-10 | -$3.07M derived: sum of 4 quarters · filed 2017-07-31 | ||
| 2016-06-30 | -$747.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | -$2.26M 10-Q · filed 2017-07-31 | -$2.48M derived: sum of 3 quarters · filed 2017-07-31 | -$2.99M derived: sum of 4 quarters · filed 2017-07-31 | ||
| 2016-03-31 | -$1.52M 10-Q · filed 2017-05-15 | -$1.74M derived: sum of 2 quarters · filed 2017-05-15 | -$2.25M derived: sum of 3 quarters · filed 2017-05-15 | -$1.43M derived: sum of 4 quarters · filed 2017-05-15 | ||
| 2015-12-31 | -$220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$730.00K derived: sum of 2 quarters · filed 2017-02-23 | $83.00K derived: sum of 3 quarters · filed 2017-02-23 | -$3.71M 10-K · filed 2017-02-23 | ||
| 2015-09-30 | -$510.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $303.00K derived: sum of 2 quarters · filed 2016-11-10 | -$3.49M 10-Q · filed 2016-11-10 | -$2.47M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-06-30 | $813.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$2.98M 10-Q · filed 2016-08-04 | -$1.96M derived: sum of 3 quarters · filed 2017-02-23 | -$2.27M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-03-31 | -$3.80M 10-Q · filed 2016-05-12 | -$2.77M derived: sum of 2 quarters · filed 2017-02-23 | -$3.08M derived: sum of 3 quarters · filed 2017-02-23 | -$2.88M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2014-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $713.00K derived: sum of 2 quarters · filed 2017-02-23 | $921.00K derived: sum of 3 quarters · filed 2017-02-23 | $2.18M 10-K · filed 2017-02-23 | ||
| 2014-09-30 | -$311.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$103.00K derived: sum of 2 quarters · filed 2015-11-12 | $1.15M 10-Q · filed 2015-11-12 | $1.38M 10-Q · filed 2014-10-30 | $1.56M derived: sum of 4 quarters · filed 2016-03-09 | |
| 2014-06-30 | $208.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.47M 10-Q · filed 2014-08-07 | $1.87M derived: sum of 3 quarters · filed 2016-03-09 | $3.94M derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2014-03-31 | $1.26M 10-Q · filed 2014-04-30 | $1.67M derived: sum of 2 quarters · filed 2016-03-09 | $3.73M derived: sum of 3 quarters · filed 2016-03-09 | $6.97M derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2013-12-31 | $409.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $2.47M derived: sum of 2 quarters · filed 2016-03-09 | $5.71M derived: sum of 3 quarters · filed 2016-03-09 | $7.56M 10-K · filed 2016-03-09 | $7.60M 10-K · filed 2014-03-11 | |
| 2013-09-30 | $2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $5.30M derived: sum of 2 quarters · filed 2014-10-30 | $7.15M 10-Q · filed 2014-10-30 | $8.08M derived: sum of 4 quarters · filed 2014-10-30 | ||
| 2013-06-30 | $3.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $5.09M 10-Q · filed 2014-08-07 | $6.02M derived: sum of 3 quarters · filed 2014-08-07 | $7.79M derived: sum of 4 quarters · filed 2014-08-07 | ||
| 2013-03-31 | $1.85M 10-Q · filed 2014-04-30 | $2.78M derived: sum of 2 quarters · filed 2014-04-30 | $4.55M derived: sum of 3 quarters · filed 2014-04-30 | |||
| 2012-12-31 | $925.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $2.70M derived: sum of 2 quarters · filed 2014-03-11 | $3.42M 10-K · filed 2014-03-11 | |||
| 2012-09-30 | $1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $2.49M 10-Q · filed 2013-11-07 | ||||
| 2012-06-30 | $718.00K 10-Q · filed 2013-08-08 | |||||
| 2011-12-31 | $247.00K 10-K · filed 2014-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |